World's Best Scientists 2026 revealed!
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Medicine

D-Index
127
Citations
97310
World Ranking
2759
National Ranking
105

Research.com Recognitions

  • 2023 - Research.com Medicine in Netherlands Leader Award

Overview

Dick de Zeeuw is affiliated with the University of Groningen in the Netherlands. Their research primarily spans the field of Medicine, with an emphasis on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nephrology, Surgery, and Pulmonary and Respiratory Medicine.

The scientist's recent publications include the following:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis, 2021, The Lancet
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis, 2021, The Lancet
  • Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial, 2020, Journal of the American Society of Nephrology
  • Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial, 2020, Journal of the American Society of Nephrology
  • Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice, 2020, Kidney International

The scientist's frequent collaborators include:

  • Hiddo J.L. Heerspink
  • Vlado Perkovic
  • Kenneth W. Mahaffey
  • Bruce Neal
  • Meg Jardine

Their work has been published extensively in several academic journals, including:

  • Journal of the American Society of Nephrology
  • Diabetes Obesity and Metabolism
  • Kidney International
  • Nephrology Dialysis Transplantation
  • Diabetes

Dick de Zeeuw's main research topics cover a range of areas related to diabetes and cardiovascular health. These include:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Chronic Kidney Disease and Diabetes
  • Blood Pressure and Hypertension Studies
  • Diabetes Management and Research
  • Hormonal Regulation and Hypertension
  • Bipolar Disorder and Treatment

Best Publications

  • EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY

    Barry M. Brenner;Mark E. Cooper;Dick De Zeeuw;William F. Keane

  • Canagliflozin and cardiovascular and renal events in type 2 diabetes

    Bruce Neal;Vlado Perkovic;Vlado Perkovic;Kenneth W. Mahaffey;Dick de Zeeuw

  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint

  • Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

    Andrew S. Levey;Kai-Uwe Eckardt;Yusuke Tsukamoto;Adeera Levin

  • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson

  • A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper

  • Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population

    Hans L. Hillege;Vaclav Fidler;Gilles F.H. Diercks;Wiek H. van Gilst

  • Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

    Hans-Henrik Parving;Hans-Henrik Parving;Barry M. Brenner;John J.V. McMurray;Dick de Zeeuw

  • Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition - A patient-level meta-analysis

    Tazeen H. Jafar;Paul C. Stark;Christopher H. Schmid;Marcia Landa

  • Renal function, neurohormonal activation, and survival in patients with chronic heart failure

    Hans L. Hillege;Armand R. J. Girbes;Pieter J. de Kam;Frans Boomsma

  • Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

    T. H. Jafar;C. H. Schmid;M. Landa;I. Giatras

  • Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

    Eric L. Knight;Jacobien C. Verhave;Donna Spiegelman;Hans L. Hillege

  • Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

    Dick De Zeeuw;Giuseppe Remuzzi;Hans Henrik Parving;William F. Keane

  • Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

    Hans L. Hillege;Dorothea Nitsch;Marc A. Pfeffer;Karl Swedberg

  • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

    Dick de Zeeuw;Tadao Akizawa;Paul Audhya;George L. Bakris

  • Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy

    Dick De Zeeuw;Giuseppe Remuzzi;Hans Henrik Parving;William F. Keane

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

    Brad C. Astor;Kunihiro Matsushita;Ron T. Gansevoort;Marije Van Der Velde

  • Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

    H. L. Hillege;W. M. T. Janssen;A. A. A. Bak;G. F. H. Diercks

  • Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

    Dick De Zeeuw;Rajiv Agarwal;Michael Amdahl;Paul Audhya

  • Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.

    H. J. Lambers Heerspink;D. de Zeeuw;L. Wie;B. Leslie

Frequent Co-Authors

Hiddo J.L. Heerspink
Hiddo J.L. Heerspink University of Groningen
Vlado Perkovic
Vlado Perkovic George Institute for Global Health
Bruce Neal
Bruce Neal George Institute for Global Health
Paul E. de Jong
Paul E. de Jong University of Groningen
Ron T. Gansevoort
Ron T. Gansevoort University Medical Center Groningen
Stephan J. L. Bakker
Stephan J. L. Bakker University Medical Center Groningen
Gerjan Navis
Gerjan Navis University Medical Center Groningen
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Barry M. Brenner
Barry M. Brenner Brigham and Women's Hospital
Hans L. Hillege
Hans L. Hillege University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional MD is not the only way to start a healthcare career in the USA. Many students explore alternative pathways through online degrees, offering flexibility and affordability. Fast-track options like the lpn program are ideal for those seeking entry-level nursing roles and a quicker path into the workforce.

For individuals interested in mental health care, advancing your career with pmhnp online programs can open doors to in-demand nurse practitioner roles. These online programs make it possible to specialize while balancing other responsibilities.

Not all healthcare careers require direct patient care. A health administration degree online prepares future leaders to manage healthcare facilities or health policy initiatives. If affordability is a concern, consider the cheapest online master degree in healthcare administration to gain essential management skills at a lower cost.

Choosing the right online degree program can fast-track your entry into the diverse and growing field of healthcare, providing both practical skills and new career opportunities.

Best Scientists Citing Dick de Zeeuw

Trending Scientists

Recently Published Articles